REQUEST A DEMO
Total
USD $0.00
Search more companies

American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing | Professional and Commercial Equipment and Supplies Merchant Wholesalers | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences
Full name: American Vietnamese Biotech Incorporation Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) is based in Vietnam, with the head office in Ho Chi Minh municipality. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on April 04, 2026. It currently has a total number of 103 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 31.48% in Q3C2025. A growth of 0.54% was recorded in its total assets. American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My)’s net profit margin increased by 28.95% in 2025.

Headquarters
4Th Floor, Phu Ma Duong Building, 85 Hoang Van Thai Street, Tan My Ward
Ho Chi Minh municipality; South Eastern Vietnam;

Contact Details: Purchase the American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) report to view the information.

Website: http://www.amvibiotech.com

Basic Information
Total Employees:
Purchase the American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) report to view the information.
Outstanding Shares:
Purchase the American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) report to view the information.
Registered Capital:
Purchase the American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) report to view the information.
Financial Auditors:
Purchase the American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) report to view the information.
Incorporation Date:
April 04, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Controller/Comptroller
Ownership Details
Purchase this report to view the information.
5.9%
Purchase this report to view the information.
4.97%
Purchase this report to view the information.
4.81%
Purchase this report to view the information.
4.61%
Purchase this report to view the information.
4.43%
Subsidiaries
Cong Ty Co Phan Phat Trien Cong Nghe Ha Long Kyoto
99%
Cong Ty Co Phan Nghien Cuu Ap Dung Cong Nghe Moi Song Hau
98%
Cong Ty Co Phan Phong Kham Ha Dong
98%
Company Performance
Financial values in the chart are available after American Vietnamese Biotech Incorporation (Cong Ty Co Phan San Xuat Kinh Doanh Duoc Va Trang Thiet Bi Y Te Viet - My) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
31.48%
Total Operating Revenue
26.28%
Operating Profit
15.99%
EBITDA
67.33%
Net Profit/Loss for the Period
20.2%
Total Assets
0.54%
Total Equity
-0.22%
Operating Profit Margin
19.03%
Net Profit Margin
28.95%
Return on Equity (ROE)
0.79%
Debt / Equity
-0.2%
Quick Ratio
-2.27%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?